First dosing at Ambade Eye Hospital in Nagpur, India, marks a key milestone in the clinical development of Treyegen™ PLANO, Texas — November 2, 2026 Okogen, Inc., a clinical-stage biotechnology company developing a host-directed antiviral platform, today announced that the